RxDoctor Payments Data

Joanna van

Family Medicine · Colton, CANPI 1639250194

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,640 of the $3,928 with a category attached, or 67.2%. Eli Lilly accounts for 98.5% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2021 at $3,871 and has fallen 99.0% since, to $40 in 2022. Among family medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,928in general payments, 2019–2025

Across 7 payments — averaging $561.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$4K
  • Sanofi-aventis U.S. LLC$58
$8,716,612in research payments, 2019–2025

Across 1,931 payments — averaging $4514.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$6.5M
  • Sanofi US Services Inc.$999K
  • Pfizer$825K
  • Novo Nordisk AS$217K
  • Genentech, Inc.$164K
  • Merck$169

What the payments were for

  • Speaking & faculty fees$2,64067%
  • Travel & lodging$1,23131%
  • Food & beverage$581%

General payments by program year

19
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly4$3,871
Sanofi-aventis U.S. LLC3$58

How this compares

$3,928 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California →

Other family medicine in Colton

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →